Aurobindo Pharma Ltd
ARBN.BO- Latest Trade
- trading lower520.15INR
- Change
- -2.4
- % Change
0.46%Negative
- Day Range
- 517.75 - 528.65
- 52-Week Range
- 503.40 - 1,008.75
As of Jul 4 2022. Values delayed up to 15 minutes
- Previous Close
- 522.55
- Open
- 523.00
- Volume
- 13,097.00
- 3 Month Average Trading Volume
- 41.38
- Shares Out (Mil)
- 585.94
- Market Cap
- 306,123.60
- Forward P/E
- 10.72
- Dividend Yield
- 1.72
Key Statistics
1.76666667 mean rating - 30 analysts
- P/E Excl. Extra Items (TTM)
- 11.56
- Price To Sales (TTM)
- 1.31
- Price To Book (Quarterly)
- 1.25
- Price To Cash Flow (Per Share TTM)
- 8.11
- Total Debt/Total Equity (Quarterly)
- 11.60
- Long Term Debt/Equity (Quarterly)
- 2.31
- Return On Investment (TTM)
- 10.81
- Return On Equity (TTM)
- 7.81
2021 (millions USD)
About Aurobindo Pharma Ltd
Company Information
Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company develops, manufactures and distributes generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients. Its product portfolio is spread over seven therapeutic/product areas encompassing central nervous systems (CNS), anti-retroviral, cardiovascular (CVS), antibiotics, gastroenterological, anti-diabetics and anti-allergic. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and Aurolife Pharma LLC, among others.
Address
Water Mark Building,, Plot No. 11 Survey no.9, Kondapur, Hitech City Hyderabad,TelanganaHYDERABAD,
500081
India
Industry
Major Drugs
Executive Leadership
- K Ragunathan
- Non-Executive Independent Chairman of the Board
- K. Nityananda Reddy
- Vice Chairman of the Board, Managing Director
- Santhanam Subramanian
- Chief Financial Officer
- B. Adi Reddy
- Compliance Officer, Company Secretary
- M. Madan Mohan Reddy
- Whole-Time Director
- P. Sarath Chandra Reddy
- Whole-Time Director
- M. V. Sivakumaran
- Whole-Time Director
- P.V. Ramaprasad Reddy
- Non-Executive Director, Promoter
- Savita Mahajan
- Non-Executive Independent Director
- Avnit Bimal Singh
- Non-Executive Independent Director
- Girish Paman Vanvari
- Additional Non-Executive Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,798.90 | -- |
| Copper | 675.50 | 0.52%Negative |
| Brent Crude Oil | 112.20 | 0.51%Positive |
| CBOT Soybeans | 1,626.00 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,825.33 | 1.06%Positive |
| Euro STOXX 50 | 3,448.31 | -- |
| FTSE 100 | 7,168.65 | 0.01%Negative |
| Nikkei 225 | 26,153.81 | 0.84%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes